Pfizer and Boehringer Ingelheim Pharmaceuticals to feature in line up at Smithers Rapra Extractables and Leachables USA Conference 2013
* Reuters is not responsible for the content in this press release.
http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130206:nBw065761a 2nd Extractables and Leachables conference held in USA in Providence, RI on May 7-9 2013. PROVIDENCE, R.I.--(Business Wire)-- Extractables and Leachables USA 2013 (E&L USA) have released their full agenda for 2013. The 3 day event will feature a pre-conference workshop, poster sessions and a 2 day speaker program covering case studies on materials composition and quality, toxicological perspectives on E&Ls and challenges in E&L studies. Smithers Rapra`s annual Extractables and Leachables conferences attract a wide range of delegates. E&L USA 2012 was attended by an expanse of companies from pharmaceutical manufacturers, medical device manufacturers, packaging and materials suppliers to CROs, government and academia. Last year over 65 delegates visited the conference, the full list of attending companies can be found here. E&L USA 2013 will cover the latest developments from industry practitioners and working groups to meet regulatory requirements and ensure compatibility in drug-package combinations. Speakers lined up include Dennis Jenke, Baxter Healthcare; Bill Beierschmitt, Pfizer, and Diane Paskiet, West Pharmaceutical Services. Dan Norwood, Distinguished Research Fellow, Boehringer Ingelheim Pharmaceuticals, is one of the keynote speakers for E&L USA and scheduled to discuss the United States Pharmacopeia and the issue of leachables and extractables: past, present and future. On current challenges with respect to E&Ls, Norwood commented "the most significant current challenge for the entire pharmaceutical landscape is reaching consensus among all of the various stakeholders regarding how to address the key issues related to E&Ls for all drug product types and medical devices." Further highlights of the conference include case studies from Johnson & Johnson, EMD Millipore and BD Medical on biodegradable and permanent implantable devices, single-use systems and elastomeric components for parenteral packaging. Plus the pre-conference workshop, led by Dr Andrew Feilden, Chemistry Operations Director and Sukhy Toot, Product Manager - Medical Devices at Smithers Rapra, will cover an introduction to extractables and leachables, material selection, risk based analysis and extractable and leachable testing. And, new for 2013, poster sessions will allow attendees to hear even more about recent research and findings relating to all areas of E&Ls. For more information on E&L USA 2013 conference visit http://www.eandl-conference.com To find out more information Smithers Rapra visithttp://www.smithersrapra.com/ Smithers Rapra Jo Martin +44 (0)1372 802000 Jomartin@smithers.com Copyright Business Wire 2013
- Gaza death toll rises; Hamas fires rockets at Tel Aviv |
- Ukraine jets pound rebels after deadly missile attack |
- Female Yahoo executive sued for sexual harassment
- Teen survivor of Texas shootings says slain family members 'in much better place'
- Trump Plaza in Atlantic City to close, adding to city's woes: report